◆ NeutralZYME

Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results

GlobeNewswire Inc.·
Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results

Zymeworks Inc. announced it will report Q3 2026 financial results on November 9, 2026, without a conference call. The company will participate in multiple investor conferences in November, including events hosted by Wolfe Research, Stifel, Truist Securities, and Jefferies in New York and London. The biotech company continues executing its strategy of building a diversified portfolio of healthcare assets including commercial products like YUPELRI® and pipeline candidates.

Read Full Article at GlobeNewswire Inc. →
← Back to Financial Intelligence